MeiraGTx Holdings (MGTX) Retained Earnings (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Retained Earnings came in at $2.4 million in Q4 2025, up 100.34% YoY from $1.2 million in Q4 2024, and up 100.29% on a QoQ basis from -$831.3 million in Q3 2025.
MeiraGTx Holdings (MGTX) Retained Earnings (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Retained Earnings data on file, last reported at $2.4 million in Q4 2025.
- Quarterly Retained Earnings rose 100.34% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (up 100.34% YoY) and the FY2025 annual result came in at $2.4 million, up 100.34% from the prior year.
- Retained Earnings rose to $2.4 million in Q4 2025, from -$831.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $791.3 million in Q2 2025 to a low of -$831.3 million in Q3 2025.
- A 5-year average of -$126.5 million and a median of -$187.3 million in 2021 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2021 — Retained Earnings jumped 23628.3% — and 2023, when it sank 204.41%.
- Tracing MGTX's Retained Earnings over 5 years: stood at -$2.7 million in 2021, then surged by 21885.59% to $581.9 million in 2022, then sank by 195.25% to -$554.2 million in 2023, then slipped by 26.67% to -$702.0 million in 2024, then jumped by 100.34% to $2.4 million in 2025.
- The last three Retained Earnings figures came in at $2.4 million (Q4 2025), -$831.3 million (Q3 2025), and $791.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.41 Mn |
| Sep 30, 2025 | -831.30 Mn |
| Jun 30, 2025 | 791.28 Mn |
| Mar 31, 2025 | -742.00 Mn |
| Dec 31, 2024 | -702.02 Mn |
| Sep 30, 2024 | -662.60 Mn |
| Jun 30, 2024 | -623.30 Mn |
| Mar 31, 2024 | -574.67 Mn |
| Dec 31, 2023 | -554.23 Mn |
| Sep 30, 2023 | -574.45 Mn |
| Jun 30, 2023 | 652.52 Mn |
| Mar 31, 2023 | -500.57 Mn |
| Dec 31, 2022 | 581.89 Mn |
| Sep 30, 2022 | 550.17 Mn |
| Jun 30, 2022 | 6.62 Mn |
| Mar 31, 2022 | -371.60 Mn |
| Dec 31, 2021 | -2.67 Mn |
| Sep 30, 2021 | -2.91 Mn |
| Jun 30, 2021 | 516.03 Mn |
| Mar 31, 2021 | 510.61 Mn |